Paper List

Hua Liao, Wei Cao, Lili Pan

Background Takayasu arteritis (TAK) requires long-term immunosuppression. Cyclophosphamide (CTX) is effective but toxic, whereas tocilizumab provides targeted IL-6 inhibition; however, comparative dat...